Claritas Pharmaceuticals Past Performance

How has Claritas Pharmaceuticals performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


21.1%

Historical Pharmaceuticals & Biotech annual earnings growth

Earnings and Revenue History

Quality Earnings: CLAS has a high level of non-cash earnings.

Growing Profit Margin: CLAS became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: CLAS has become profitable over the past 5 years.

Accelerating Growth: CLAS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: CLAS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (39.8%).


Return on Equity

High ROE: CLAS's Return on Equity (55%) is considered outstanding.


Discover strong past performing companies